Cargando…

Editorial Comment: Endoclips as novel fiducial markers in trimodality bladder preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes

Detalles Bibliográficos
Autores principales:	dos Reis, Rodolfo Borges, Muglia, Valdair Francisco, Rodrigues, Antônio Antunes, Viani, Gustavo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2020
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712691/ https://www.ncbi.nlm.nih.gov/pubmed/33047915 http://dx.doi.org/10.1590/S1677-5538.IBJU.2019.0713.1

Ejemplares similares

Endoclips as novel fiducial markers in trimodality bladder-preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes
por: Shahbaz, Muhammad, et al.
Publicado: (2020)

Editorial Comment: Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2020)

Editorial Comment: Evaluation of HIF-1α and VEGF-A expression in radiation-induced cystitis: A case-control study
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2021)

Node dissection in prostate cancer: no answers for old questions
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2021)

The dilemma of partial nephrectomy and surgical upstaging
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2022)

Trimodality Therapy for Bladder Preservation in the Elderly Population with Invasive Bladder Cancer
por: Turgeon, Guy-Anne, et al.
Publicado: (2014)

Single Institutional Experience of Bladder-Preserving Trimodality Treatment for Muscle-Invasive Bladder Cancer
por: Joung, Jae Young, et al.
Publicado: (2008)

Editorial Comment to Testicular metastasis from urothelial carcinoma of the bladder
por: Yuasa, Takeshi
Publicado: (2021)

Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes
por: Garcia, Maurice M., et al.
Publicado: (2014)

Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients
por: Arafat, Waleed, et al.
Publicado: (2016)

Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes
por: Garcia, Maurice M., et al.
Publicado: (2016)

Editorial Comment to Clinical characteristics of patients with inguinal hernia mesh migration into the bladder
por: Nakamura, Masaki
Publicado: (2022)

Editorial Comment to Functional paraganglioma of the bladder: Both radiographic‐negative and laboratory‐negative case
por: Tabei, Tadashi
Publicado: (2019)

Editorial Comment to Combination of en bloc transurethral resection with laparoscopic partial cystectomy for paraganglioma of the bladder
por: Hashimoto, Takeshi
Publicado: (2019)

Editorial Comment to Progressive plasmacytoid variant bladder cancer with retroperitoneal dissemination: An autopsy case report
por: Hayashi, Tetsutaro, et al.
Publicado: (2020)

Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer
por: Ajib, Khaled, et al.
Publicado: (2018)

Trimodality Treatment for Muscle-Invasive Bladder Cancer: An Institutional Experience
por: Polineni, Praneet, et al.
Publicado: (2021)

Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Tomisaki, Ikko
Publicado: (2019)

Editorial comment: Cross-cultural adaptation and validation of the neurogenic bladder symptom score questionnaire for brazilian portuguese
por: Welk, Blayne
Publicado: (2019)

Editorial Comment to Bladder stone formation around polyethylene glycol after use of SpaceOAR hydrogel
por: Morita, Masashi
Publicado: (2023)

The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer
por: Miyata, Haruka, et al.
Publicado: (2020)

Oncological effectiveness of bladder-preserving trimodal therapy versus radical cystectomy for the treatment of muscle-invasive bladder cancer: a system review and meta-analysis
por: Su, Xiaozhe, et al.
Publicado: (2023)

The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer
por: Russell, Christopher M., et al.
Publicado: (2016)

Trimodal Therapy Using an MR–guided Radiation Therapy Partial Bladder Tumor Boost in Muscle Invasive Bladder Cancer
por: Liveringhouse, Casey, et al.
Publicado: (2023)

Editorial Comment: Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients
por: Korkes, Fernando
Publicado: (2021)

Comments on “Transcutaneous tibial nerve stimulation versus parasacral stimulation in the treatment of overactive bladder in elderly people: A triple-blinded randomized controlled trial”
por: Srivastav, Apoorva, et al.
Publicado: (2020)

Editorial Comment on: A. Smereczyński, T. Szopiński, T. Gołąbek, O. Ostasz and S. Bojko Sonography of tumors and tumor-like lesions that mimic carcinoma of the urinary bladder
por: Crisan, Nicolae, et al.
Publicado: (2014)

Editorial Comment: Parasacral transcutaneous electrical nerve stimulation in children with overactive bladder: comparison between sessions administered two and three times weekly
por: Silva, José Ailton Fernandes
Publicado: (2021)

Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans
por: Kumar, Abhishek, et al.
Publicado: (2021)

Editorial comment: Renal denervation
por: Schmieder, Roland E., et al.
Publicado: (2021)

Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis
por: Ding, Hui, et al.
Publicado: (2020)

Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer
por: Guo, Yadong, et al.
Publicado: (2019)

VI-RADS score system - A primer for urologists
por: Nicola, Refky, et al.
Publicado: (2022)

Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer
por: Bachir, Bassel G., et al.
Publicado: (2017)

Conditional survival of trimodal therapy for nonmetastatic muscle‐invasive bladder cancer: A SEER database analysis
por: Shangguan, Wentai, et al.
Publicado: (2022)

Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy
por: Magliocco, Anthony M., et al.
Publicado: (2022)

Trimodality Therapy in which Concurrent Chemoradiation with Concomitant Boost in Muscle Invasive TCC Urinary Bladder Cancer
por: Mohammed, Ayatallah Ali Youssief, et al.
Publicado: (2023)

Editorial Comment to A case in which bladder cancer invaded the ureteral orifice and was resected via photodynamic diagnosis‐assisted transurethral resection involving orally administered 5‐aminolevulinic acid
por: Nakai, Yasushi, et al.
Publicado: (2019)

Editorial Comment
por: Madbouly, Khaled
Publicado: (2011)

EDITORIAL COMMENT
por: Mladenov, Dimitar
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4m5e8n85t3hbotupksuu8chkgj